Related Experiment Video
Updated: Dec 13, 2025

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
[Orphan drugs, incentives and uncertainty about their risk-benefit balance]
Leire Leache1, Luis Carlos Saiz1, Marta Gutiérrez-Valencia1
1Sección de Innovación y Organización, Servicio Navarro de Salud-Osasunbidea, Pamplona, España.
No abstract available in PubMed .
More Related Videos
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drug Products: Biologics, Biosimilars and Interchangeables
Bioequivalence studies: Biowaivers
Drug Regulation
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence